117
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

, , , , , & show all
Pages 1019-1025 | Published online: 06 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jingping Zhao, Kaida Jiang, Qingwei Li, Yanlei Zhang, Yan Cheng, Ziyi Lin & Jianwei Xuan. (2019) Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China. Journal of Medical Economics 22:5, pages 439-446.
Read now

Articles from other publishers (8)

Ekapol Limpongsa, Peera Tabboon, Thaned Pongjanyakul & Napaphak Jaipakdee. (2022) Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique. Pharmaceutics 14:11, pages 2407.
Crossref
Katarzyna Bialik-Wąs, Katarzyna Żyła, Dagmara Malina, Krzysztof Pielichowski, Katarzyna Malarz & Anna Mrozek-Wilczkiewicz. (2021) Examining the influence of olanzapine on the protein adsorption on the surface of biodegradable poly(hydroxybutyrate-co-hydroxyvalerate) nano/micro-carriers. Applied Surface Science 565, pages 150543.
Crossref
Robert-Alexandru Vlad, Paula Antonoaea, Nicoleta Todoran, Daniela-Lucia Muntean, Emőke Margit Rédai, Oana Alexandra Silași, Anamaria Tătaru, Magdalena Bîrsan, Silvia Imre & Adriana Ciurba. (2021) Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets. Saudi Pharmaceutical Journal 29:9, pages 1029-1042.
Crossref
Asta Ratna Prajapati, Alexandra Dima, George Mosa, Sion Scott, Fujian Song, Jonathan Wilson & Debi Bhattacharya. (2021) Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review. Psychological Medicine 51:7, pages 1082-1098.
Crossref
Keitaro Tachi, Taeko Fukuda & Makoto Tanaka. (2021) Olanzapine attenuates postoperative cognitive dysfunction in adult rats. Heliyon 7:2, pages e06218.
Crossref
Emine Tashan, Alptug Karakucuk & Nevin Celebi. (2020) Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation. AAPS PharmSciTech 21:3.
Crossref
Mai Sotoyama, Shinya Uchida, Chiaki Kamiya, Shimako Tanaka, Yasuharu Kashiwagura, Akio Hakamata, Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe & Noriyuki Namiki. (2019) Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets. Chemical and Pharmaceutical Bulletin 67:6, pages 540-545.
Crossref
Ludmila Alvim Pinho, Ana Claudia Temer, Caroline Ribeiro, Livia Lira Sá-Barreto & Marcilio Sergio Soares Cunha-Filho. (2018) THE POPULARIZATION OF ORODISPERSIBLE TABLETS IN THE PHARMACEUTICAL MARKET. Infarma - Ciências Farmacêuticas 30:2, pages 77-84.
Crossref